check_circleStudy Completed

Bacterial Infection

Bayer Identifier:

Trial_10110

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Comparison of the efficacy and safety of ciprofloxacin with erythromycin in children with cholera.

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

2 - 10 Years
  • -

  • -

Trial summary

Enrollment Goal
180
Trial Dates
May 2001 - July 2002
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Cipro (Ciprofloxacin, BAYQ3939)
Accepts Healthy Volunteer
N/A

Trial design

An open, randomized clinical study comparing the efficacy and safety of a single dose of ciprofloxacin with erythromycin administered 6-hourly for 3 days in children with cholera
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.